Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Phytest
AddedFeb 15, 2024
UpdatedJun 18, 2026
Phytest

Phytest

Phytest: Streamlining lab revenue cycles with cutting-edge tech solutions and transparent RCM services.

HQ
Atlanta, GA, US
Founded
1998
Overview
Compare
Fundraising
Employees
Website

Phytest is a technology-focused revenue cycle management (RCM) solution provider dedicated to partnering with laboratories of all sizes to enhance revenue and efficiency. The company offers advanced RCM technology solutions and managed laboratory services, including lab billing automation through its Phytest Atlas RCM platform. This platform ensures streamlined revenue cycles, reduced costs, and increased payment accuracy, providing lab owners with unparalleled transparency and confidence in maximizing revenue.

Phytest has established itself as a leader in the laboratory RCM industry by focusing exclusively on recovering revenue for labs. Its innovative approach and expertise have led many laboratories to switch from traditional medical billing companies to Phytest's specialized services. The company's impact is evident in its ability to hold insurance companies accountable and ensure that laboratories receive due payments, significantly improving the financial health and operational efficiency of its clients.

Phytest - Similar Companies

Med-Metrix logo

Med-Metrix

med-metrix.com

SiteLabs logo

SiteLabs

sitelabsglobal.com

Telcor logo

Telcor

telcor.com

Encoda logo

Encoda

encoda.com

R1 Rcm logo

R1 Rcm

r1rcm.com

CliniCast logo

CliniCast

clinicast.net

Phoresa logo

Phoresa

MCSquared Health logo

MCSquared Health

Phi Life Sciences logo

Phi Life Sciences

careviso logo

careviso

careviso.com

Phdx logo

Phdx

PatientFocus logo

PatientFocus

patientfocus.com

RCM Brain logo

RCM Brain

Hive logo

Hive

hiverevenue.com

Electronic Lab Logs logo

Electronic Lab Logs

lablogs.co

Phytest - Quick Facts

Who are Phytest's competitors?

Companies similar to Phytest include Med-Metrix, SiteLabs, Telcor and Encoda.

When was Phytest founded?

Phytest was founded in 1998.

Where is Phytest's headquarters located?

Phytest's headquarters is located in Atlanta, GA, US.

When was Phytest's last funding round?

Phytest's most recent funding round was for $330k (USD) in August 2023.

How much has Phytest raised to-date?

As of Aug 15, 2023, Phytest has raised a total of $330k (USD).

How many employees does Phytest have?

Phytest has 41 employees as of Feb 4, 2024.

Phytest - Classification

Industry
  • Professional Service Companies
Ownership
  • Private
Technology
  • Automation
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Enterprise
Main Product
  • Lab Billing
  • RCM
Tags
  • Fintech
  • SaaS
NAICS
  • 622000Hospitals
  • 622100General Medical and Surgical Hospitals
  • 622110General Medical and Surgical Hospitals
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
ISIC
  • 7810Activities of employment placement agencies
Show 9 more industry codes
NAICS
  • 561300Employment Services
  • 561310Employment Placement Agencies and Executive Search Services
  • 561311Employment Placement Agencies
  • 560000Administrative and Support and Waste Management and Remediation Services
  • 561000Administrative and Support Services
SIC
  • 7360Personnel Supply Services
  • 7361Employment Agencies
  • 8060Hospitals
  • 7300Business Services